Document is current
Any future updates will be listed below
-
Authors
Ahimbisibwe, Cynthia
Kwizera, Richard
Ndyetukira, Jane Frances
Namujju, Olivie Carolyne
Sadiq, Alisat
Atukunda, Mucunguzi
Skipper, Caleb P.
Boulware, David R.
Meya, David B.
- License Information
-
More Information
Article History
Received: 23 January 2025
Accepted: 1 July 2025
First Online: 15 July 2025
Declarations
:
: This was an observational sub-study that was nested under the ENACT trial which was approved by the Mulago Hospital Research Ethics Committee (1195); University of Minnesota Ethics Committee (STUDY00000139); Uganda National Council of Science & Technology (HS 2351); Uganda National Drug Authority (854/NDA/DPS/08/2018); United States Food and Drug Administration (IND 72807). All participants were adults aged 18 years and above. Participants provided informed consent for study participation in the ENACT trial and all its sub-studies including storage of samples for future use. The study was carried out in compliance with the international good clinical practice guidelines and the Helsinki Declaration.
: Not applicable.
: The authors declare no competing interests.
